Background: Mechanisms that elicit mucosal T H 17 cell responses have been described, yet how these cells are sustained in chronically inflamed tissues remains unclear.
Objective: We sought to understand whether maintenance of lung T H 17 inflammation requires environmental agents in addition to antigen and to identify the lung antigen-presenting cell (APC) types that sustain the self-renewal of T H 17 cells. Methods: Animals were exposed repeatedly to aspiration of ovalbumin alone or together with environmental adjuvants, including common house dust extract (HDE), to test their role in maintaining lung inflammation. Alternatively, antigen-specific effector/memory T H 17 cells, generated in culture with CD4
1
T cells from Il17a fate-mapping mice, were adoptively transferred to assess their persistence in genetically modified animals lacking distinct lung APC subsets or cell-specific Toll-like receptor (TLR) 4 signaling. T H 17 cells were also cocultured with lung APC subsets to determine which of these could revive their expansion and activation. Results: T H 17 cells and the consequent neutrophilic inflammation were poorly sustained by inhaled antigen alone but were augmented by inhalation of antigen together with HDE. This was associated with weight loss and changes in lung physiology consistent with interstitial lung disease. Inhaled compounds in the environment that stimulate innate immune pathways are critical for the priming of antigen-specific T-cell responses in the lungs. Yet it is unclear how such responses are sustained in chronically inflamed tissues after the onset of inflammation. IL-17 family member-producing T H 17 cells have been implicated in patients with numerous chronic inflammatory diseases, including respiratory diseases, such as chronic obstructive pulmonary disease, 1 hypersensitivity pneumonitis, 2 cystic fibrosis, 3, 4 and asthma. 5, 6 T H 17 cells produce IL-17A and IL-17F, both of which signal through a heterodimeric receptor comprising IL-17 receptors A and C. In the lung, IL-17A binding to its receptor on airway epithelial cells induces neutrophil-attracting chemokines, such as IL-8, in human subjects and CXCL1 and CXCL5 in mice. 7 In addition, IL-17A can also act directly on airway smooth muscle, 8 epithelial cells, 9 fibrocytes, 10 and fibroblasts 11, 12 to elicit the synthesis of proinflammatory and profibrotic mediators. Consequently, IL-17A can promote pathologies, such as airway hyperresponsiveness, fibrosis, and remodeling. Unlike T H 2 cells, which are associated with predominantly eosinophilic asthma, T H 17 cells are resistant to glucocorticoids, 13 and there is an unmet need for new therapeutic strategies that target T H 17-dependent inflammation. An improved understanding of how T H 17 cells are maintained and reactivated in the diseased lung would help to achieve this goal.
The development of antigen-specific T H 17 responses depends on activation of lung antigen-presenting cells (APCs) by inhaled environmental adjuvants, including microbial products, such as LPS, which signals through Toll-like receptor (TLR) 4.
14 Inhalation of house dust extract (HDE) can also promote T H 17 development, and this activity is largely dependent on TLR4. Studies suggest that TLR4 signaling specifically in hematopoietic cells of the lungs is important for T H 17 cell development. 15, 16 However, once T H 17 cells occupy the lungs, it is unclear whether they require continued stimulation by adjuvants or whether antigen alone is sufficient to maintain their self-renewal.
It is also unknown which MHC class II-displaying APCs in the lungs are responsible for sustaining tissue-resident T H 17 cells. Conventional dendritic cells (cDCs) in the lungs are characterized by their dependence on the cytokine FMS-like tyrosine kinase 3 ligand (Flt3l) and can be divided into 2 distinct populations: transcription factor basic leucine zipper ATF-like transcription factor 3 (BATF3)-dependent CD103 [17] [18] [19] [20] [21] [22] [23] [24] In the present report we show that chronic antigen challenges alone, after cessation of adjuvant exposures, poorly sustain lung T H 17-dependent inflammation. T H 17 adoptive transfer and fate-mapping experiments reveal that HDE sustains the self-renewal of antigen-specific T H 17 cells, promoting severe neutrophilic inflammation, morbidity, and impaired lung function reminiscent of chronic hypersensitivity pneumonitis. This effect is dependent on TLR4 signaling in multiple cell types, although primarily in hematopoietic and CD11c-expressing cells. cDCs are the only APCs capable of reviving T H 17 responses ex vivo, and both subsets sustain T H 17 responses in the lungs.
METHODS Animals
Mice were bred and housed in specific pathogen-free conditions at the National Institute of Environmental Health Sciences and used between 6 and 12 weeks of age in accordance with guidelines provided by the Institutional Animal Care and Use Committees. The following mouse strains were purchased from the Jackson Laboratory (Bar Harbor, Me):
129S1-Il12a tm1Jm /J), and Il12p40 2/2 (B6.129S1-Il12btm1Jm/J). Il17ra mice (C57BL/6-flt3Ltm1Imx) were also purchased from Taconic Farms. Il17a/f 2/2 (C57BL/6-Il17a/Il17f tm1.1Impr ) 25 and Tlr4 2/2 (B6.129P2-Tlr4 tm1 Aki ) mice were provided by Immo Prinz (Hannover, Germany) and Shizuo Akira (Osaka University, Japan), respectively.
We generated Il17a fate-mapping mice in which DNA encoding a Cre recombinase/yellow fluorescent protein (YFP) fusion protein was inserted into the 39 untranslated region of Il17 downstream of an engineered internal ribosome entry site (Il17-cre mice; see Fig E1, A, in this article's Online Repository at www.jacionline.org). These animals were crossed to mice having a Cre-inducible Tomato transgene at the Rosa26 locus (see Fig E1, B) . The resulting animals (see Fig E1, C) were in turn crossed to OT-II mice to generate ovalbumin (OVA)-specific T H 17 fate-mapping mice whose Il17-expressing cells (and their progeny) permanently acquire Tomato fluorescence (see Fig E1, D) . Fluorescence resulting from the Cre/ YFP fusion gene was undetectable and therefore not used in the current study.
Bone marrow chimeric mice
Reciprocal bone marrow chimeric mice were generated by using C57Bl/6J or Tlr4 2/2 mice, as described in the Methods section in this article's Online
Repository at www.jacionline.org. Before their use in experiments, chimeric mice were rested for 12 to 16 weeks to allow for hematopoietic reconstitution. Mice selectively lacking Tlr4 in lung epithelial cells were generated by crossing Tlr4 fl/fl mice to surfactant protein C (Sftpc)-cre mice, provided by Brigid Hogan (Duke University, Durham, NC). Mice lacking TLR4 in Cd11c-expressing cells were generated by crossing Tlr4 fl/fl mice to Cd11c-cre mice.
HDEs
Sterile HDEs were prepared from dust collected from North Carolinian homes, as described previously. 26 Allergens in the extracts were evaluated by using the multiplex array for indoor allergens (Indoor Biotechnologies, Charlottesville, Va), and the endotoxin concentration was determined to be 10 21 mg of LPS/20 mL of HDE, as determined by using a Limulus Amebocyte
Lysate assay (Lonza, Karlsruhe, Germany).
Chronic antigen exposure
Naive CD4 1 cells were isolated from the spleens and skin-draining lymph nodes of OT-II mice by using antibody-labeled magnetic bead-mediated negative selection (autoMACS; Miltenyi Biotec, Bergisch Gladbach, Germany). Cells (1 3 10 5 ) were transferred by means of retro-orbital injection to naive C57BL/6J animals, which were sensitized on days 0 and 7 by oropharyngeal instillation of 60 mL of sterile PBS containing 10 mg of LPS-free OVA (Worthington Biochemical, Lakewood, NJ), either alone or together with an adjuvant. The adjuvants tested included 100 ng of LPS from Escherichia coli 0111:B4 (Sigma-Aldrich, St Louis, Mo), 20 mg of protease from Aspergillus oryzae (Sigma-Aldrich), or 10 mL of HDE. Similar exposures were repeated on days 14 to 16 (''acute challenge'') to establish airway inflammation. This was followed by a 6-week period of chronic challenge, during which the animals were given either OVA alone or OVA together with the same adjuvant to which they had previously been exposed, 3 times per week. Mice were harvested 3 days after the final challenge (Fig 1, A) . Bronchoalveolar lavage (BAL) was performed, and cells were analyzed by the Diff-Quik method (Medical Diagnostics, D€ udingen, Germany). Left lungs were excised and incubated for 24 hours at 378C in complete Iscove's modified Dulbecco's medium (cIMDM) containing 10 mg/mL OVA to evaluate the antigen-stimulated lung explant cytokine response ex vivo.
Analysis of cytokines in BAL fluid, lung explants, and culture supernatants Levels of IL-17A and other mediators were measured by means of ELISA (BioLegend, San Diego, Calif) or multiplex fluorescent bead-based immunoassays, according to the manufacturer's instructions (Bio-Rad Laboratories, Hercules, Calif).
OVA-specific immunoglobulin
OVA-specific IgG 1 and IgG 2a from serum were evaluated by using commercial ELISA kits purchased from Thermo Fisher Scientific (Waltham, Mass) and Invitrogen BD Biosciences (San Diego, Calif), respectively. Briefly, plates were coated overnight at room temperature with 10 mg/mL OVA Grade V (Sigma) in coating buffer containing 1.94 g/L NaHCO 3 and 3.52 g/L Na 2 CO 3 in deionized H 2 O (pH 9.6). The plates were washed 3 times with 0.05% Tween 20 in PBS, blocked with 200 mL of PBS containing 1% BSA (Gemini Biosciences, Liverpool, United Kingdom) for 1.5 hours, and then washed 3 more times. One hundred microliters of serum at 1:20 dilutions for IgG 2a and 1:100 dilutions for IgG 1 were added and incubated for 2 hours. The remaining steps of the protocol were carried out exactly as described by the manufacturers.
OVA-specific T H 17 differentiation

Naive CD4
1 T cells were isolated by means of negative selection from the spleens and skin-draining lymph nodes of OT-II IL17a fate-mapping mice, as described in the Methods section in this article's Online Repository. DCs were isolated from the enzymatically digested lungs of wild-type (WT) C57BL/6J mice and enriched by means of positive selection with anti-CD11c antibodies and the autoMACS system (Miltenyi Biotec). Naive CD4 1 T cells (1 3 10 6 ) were cultured together with 0.5 3 10 6 splenic DCs in 2 mL of cIMDM containing 10 mg/mL OVA 323-339 peptide. To generate T H 17 cells, rhTGF-b (3 ng/mL), rIL-1a (10 ng/mL), rIL-6 (10 ng/mL), anti-IL-2 mAb (10 mg/mL), anti-IL-4 mAb (10 mg/mL), anti-IL-12 mAb, and anti-IFN-g mAb (5% concentration of respective hybridoma supernatants) were added to the culture. T H 17 cells were split on day 3 of culture by adding the same cocktail of cytokines and antibodies (minus OVA peptide) and with the addition of rIL-23 (10 ng/mL). The cells were split again on day 5 by using cIMDM containing IL-6 and IL-23 only (10 ng/mL).
Fate mapping of antigen-specific T H 17 cells (2), followed by chronic challenge with either OVA alone (white columns) or together with the same adjuvant used during sensitization (black columns). C, OVA-specific IgG 2a and IgG 1 levels in serum. D, Cytokines in supernatants of lung explants stimulated ex vivo with OVA. Data shown are from 4 independent experiments (n 5 8 per group). *P < .05, **P < .01, and ****P < .0001, OVA only versus OVA/adjuvant challenge.
after the final challenge (day 9), and Tomato 1 cells were analyzed by using flow cytometry (Fig 2, B) .
Live confocal imaging of inflammatory cells in the lungs
Fluorescent imaging of cells in freshly harvested, unfixed lung tissue slices was performed, as previously described, 27 after adoptive transfer of in vitro-differentiated T H 17 cells and OVA/HDE challenge. Precision-cut lung slices were prepared from the right superior lobes of agarose-inflated lungs with a Compresstome VF-300 (Precisionary Instruments, Greenville, NC). The lung slice was stained with a blocking solution containing fluorochrome-conjugated antibodies against CD324/E-cadherin, CD11c, CD88, CD103/alpha E integrin, or CD172/Sirp1a. An LSM-880 Airyscan confocal microscope (203 objective lens) was used to generate a z-stack across the entire lung slice. The images were then superimposed and processed with Zen Black 2012 software (Carl Zeiss AG, Chesterfield, Va) to yield a 2-dimensional image of Tomato fluorescent T H 17 cells and lung APCs within the whole lung slice. Alternatively, a 633 oil immersion lens was used for high-resolution imaging of lung cells interacting with Tomato 1 T H 17 cells in situ. Imaris software (version 8.4; Bitplane AG, Zurich, Switzerland) was used to generate 3-dimensional surface renderings of these cell-cell interactions.
Lung function testing
Animals were anesthetized (intraperitoneal urethane, 2 g/kg; SigmaAldrich) and mechanically ventilated with a flexiVent FX small-animal ventilator (SCIREQ Scientific Respiratory Equipment, Montreal, Quebec, Canada). Paralysis was induced with pancuronium bromide (2 mg/kg; Sigma-Aldrich) administered intraperitoneally to eliminate interference from spontaneous breathing efforts, and animals were then inflated to a pressure of 30 cm H 2 O over 3 seconds and held at that pressure for another 3 seconds to normalize baseline lung volumes. Quasistatic pressure-volume curves were generated with a stepwise, pressure-controlled perturbation. Resulting pressure-volume data were then fit to the Salazar-Knowles equation by using the operating software flexiWare (version 7.5.3), from which the K parameter (concavity/curvature of the deflation limb of the pressurevolume loops) and compliance (slope) were extracted. 28 
Analysis and isolation of lung APCs
Lungs were perfused and enzymatically digested, as described previously. 29 Low-density cells were stained with fluorochrome-conjugated mAbs against CD88, Siglec-F, CD11c, I-A b , Ly6G, Ly6C, CD11b, and CD103. Cell viability was determined with 7-aminoactinomycin D or allophycocyanin (APC)-eFluor 780 fixable viability dye. cDCs were identified as nonautofluorescent Siglec-F 2 CD88 2 CD11c 1 I-A b hi cells, 30 as shown in Fig E2 in this article's Online Repository at www.jacionline.org. Stained cells were acquired on an LSRII flow cytometer using FACSDiva software (BD Biosciences) or sorted with a BD FACSAria II (purity of the sorted populations was > 95%). Lung B cells were analyzed from the lymphocyte fraction by using fluorochrome-conjugated mAbs against CD19, B220, and I-A b or sorted by means of negative selection with a MACS LD column (purity > 75%). The costimulatory molecules CD40 and CD86 were also analyzed in lung CD11c-expressing APCs and B cells.
Coculture of lung APC subsets with mature T H 17 cells
To determine which lung APC subsets might be responsible for maintaining T H 
Statistical analysis
Data were analyzed with GraphPad Prism 7 software (GraphPad Software, La Jolla, Calif) and are presented as means 6 SEMs. Differences between groups of 3 or more were identified by using ANOVA and Newman-Keuls multiple comparison tests. Data were log-transformed before statistical analysis when not normally distributed, and a P value of less than .05 was considered statistically significant.
RESULTS
Chronic exposure to environmental adjuvants is necessary to sustain lung inflammation
We first tested whether continued exposure to adjuvants becomes dispensable for sustaining allergic pulmonary inflammation after it has developed in the lungs. To do this, we transferred naive T cells from OT-II mice (which bear a transgene encoding an OVA-specific T-cell receptor [TCR]) into C57BL/6J recipient mice and then sensitized them twice through the airways, 1 week apart, with OVA mixed with an adjuvant, LPS, HDE, or a protease extract from Aspergillus oryzae (Asp ; Fig 1,  A) . The animals were then challenged acutely in the same manner on 3 additional occasions on days 14 to 16 to activate antigen-specific T cells and establish allergic airway inflammation. Experimental groups then continued to receive either chronic OVA exposures with the same adjuvant or just OVA alone.
As expected, mice that inhaled OVA without an adjuvant did not become sensitized and did not have allergic inflammation after subsequent OVA challenge, which is in agreement with previous results.
14 Surprisingly, however, mice receiving OVA together with an adjuvant during sensitization and acute challenge but challenged with OVA alone for the remainder of the protocol also displayed relatively little inflammation (Fig 1, B) . By contrast, mice challenged chronically with OVA together with an adjuvant displayed robust pulmonary inflammation, the nature of which depended on which adjuvant had been inhaled. Thus mice challenged with OVA together with Asp (OVA/Asp) displayed predominantly eosinophilic inflammation, whereas mice challenged with OVA together with either LPS (OVA/LPS) or HDE (OVA/HDE) displayed neutrophilic inflammation with few eosinophils. Notably, neutrophil numbers were even greater in mice challenged with OVA/HDE than in those challenged with OVA/LPS. OVA-specific levels of the T H 1/T H 17-associated immunoglobulin isotype IgG 2a were greatest in mice challenged chronically with OVA/LPS but were also increased in mice challenged with OVA/HDE (Fig 1, C) . This isotype was relatively low in mice challenged with OVA/Asp. By contrast, the nature of the adjuvant during sensitization had little effect on levels of OVA-specific IgG 1 , which is associated with type 2 responses.
Pathogenic T H 17 responses in the lung are sustained by inhalation of adjuvants that activate TLR4
Lungs were harvested from animals and incubated overnight in the presence of OVA to assess the effect of the chronic adjuvant exposures on antigen-induced cytokine production. Lung explant supernatants from mice challenged chronically with OVA/Asp had higher amounts of IL-4 than the other groups (Fig 1, D) , although levels of this cytokine were low, and there were no significant differences among the groups in IL-13 levels (data not shown). Mice challenged with OVA/HDE had increased levels of IL-17A. This suggested that inhalation of HDE, together with OVA, can sustain the antigen-specific T H 17 response in the lungs. To test this directly, we crossed OT-II mice to Il17a fate-mapping mice in which a Cre recombinase gene that is expressed in conjunction with Il17a permanently activates expression of a gene encoding a tandem dimer Tomato fluorescent protein (see Fig E1) . Thus we were able to differentiate OVA-specific pathogenic T H 17 cells from these animals in vitro and use their fluorescence to follow the fate of these cells (and their progeny) after adoptive transfer. Approximately half of the in vitro-differentiated T cells were positive for Tomato, and virtually all expressed the effector/memory T-cell marker CD44 (Fig 2, A) . Further analysis of these cells indicated that they were capable of producing IL-17A, IL-17F, IL-6, and TNF-a but produced little IL-4 and no IFN-g (data not shown) and thus acquired a characteristic pathogenic T H 17 phenotype described previously. 31 The T H 17 fate-mapping cells were adoptively transferred into recipient mice lacking both IL-17A and IL-17F (Il17a/ f 2/2 mice) to ensure that the Tomato 1 T H 17 cells would be the sole source of these cytokines.
All animals received a first challenge with OVA/HDE to establish airway inflammation and were then divided into groups that were challenged every second day with OVA alone, HDE alone, or OVA/HDE (Fig 2, B) . Animals challenged repeatedly with OVA/HDE displayed significantly increased total BAL fluid leukocyte counts (Fig 2, C) and, importantly, Tomato 1 cell numbers (Fig 2, D) , indicating a higher number of T H 17 cells in the airways originating from the adoptively transferred population. Consistent with the increase in T H 17 cell numbers, OVA/HDE also augmented BAL fluid neutrophil numbers (Fig 2, C) and BAL fluid and lung explant IL-17A cytokine levels in the Il17a/f 2/2 mice (Fig 2, E) . A small number of eosinophils was also observed, possibly from an innate immune response triggered by HDE or small numbers of T H 2 cells.
We next explored whether inhaled HDE can affect the pathogenicity of the adoptively transferred T H 17 cells (ie, their production of IL-17 cytokine on a per-cell basis) in addition to increasing their numbers. We performed conventional intracellular staining, as well as a flow cytometry-based cytokine capture assay to evaluate IL-17 being actively secreted by stimulated Tomato 1 cells. Neither approach revealed differences between OVA-and OVA/HDE-treated mice in the proportion of Tomato 1 cells expressing IL-17A or IL-17F or in the median fluorescence intensity (MFI) of those cytokines (see Fig E3 in this article's Online Repository at www.jacionline.org). However, lungs of OVA/HDE-challenged mice had greater numbers of IL-17A-secreting Tomato 1 cells compared with mice challenged with OVA alone (see Fig E3, C) , which is consistent with the differences observed in BAL fluid. Total numbers of Tomato 1 T H 17 cells were far greater than numbers of adoptively transferred cells, indicating that HDE augmented the selfrenewal of these T H 17 cells. Examination of precision-cut lung slices confirmed that numbers of Tomato 1 cells in the lung increased after multiple OVA/HDE challenges and further revealed that these cells localized initially around the airways but were distributed diffusely within the lungs after additional challenges (Fig 2, F) . Collectively, these experiments demonstrated that HDE augmented the T H 17 response deriving from adoptively transferred T H 17 cells and thus the recall T H 17 response to an unrelated antigen that is concomitantly inhaled.
OVA/HDE challenge also caused significant weight loss in T H 17 cell recipients, whereas challenge with OVA or HDE alone did not (Fig 2, G) . Weight loss is a comorbidity of chronic lung diseases, such as chronic obstructive pulmonary disease 32 and hypersensitivity pneumonitis, 33 likely because of a combination of compromised air exchange, reduced cardiac function, and reduced airflow. Analysis of lung function in T H 17 cell recipients further revealed that OVA/HDE-challenged animals also had flatter pressure-volume curves, as indicated by the significantly lower K value extracted from these curves (Fig 2, H) . Moreover, these animals also showed a trend toward lower static compliance of the lungs (Fig 2, H) and inspiratory capacity (data not shown). Overall, these changes are consistent with an increased stiffness of the lungs, a common clinical feature of interstitial lung diseases, such as pulmonary fibrosis and chronic hypersensitivity pneumonitis. 34 Using Il17a/f 2/2 and Il17ra 2/2 mice as recipients, we confirmed that IL-17 production by the transferred T H 17 cells was responsible for the observed phenotype (see Fig  E4 in this article's Online Repository at www.jacionline.org). Thus the outcomes observed after T H 17 adoptive transfer and repeated OVA/HDE exposure were caused specifically by the sustained expansion and activation of the transferred cells rather than a de novo T H 17 response in the treated animals.
HDEs are crude extracts containing numerous allergens, microbial products, enzymes, and a variety of other compounds. To determine whether an enzyme or other heat-labile molecule is responsible for the ability of HDE to sustain T H 17 responses, we heat inactivated the extract at 908C for 30 minutes. Surprisingly, there was no difference between intact and heat-inactivated HDEs on the T H 17 response or other outcomes (Fig 3, A-C) , indicating that a heat-stable agent within the HDE is responsible for the maintenance of T H 17 cells. Endotoxin is one such component, and we have previously reported that induction of lung T H 17 responses by HDE is mediated through TLR4. 15 Therefore we investigated whether HDE also sustains lung T H 17 responses through TLR4 signaling.
Remarkably, despite its rich composition, the effect of HDE in boosting OVA-specific T H 17 cells was entirely TLR4 dependent; Tlr4 2/2 recipients had significantly lower numbers of BAL fluid neutrophils and Tomato 1 cells, as well as lower lung explant IL-17A cytokine levels (Fig 3, A-C) . Tlr4 2/2 mice also lost significantly less weight than did WT mice (Fig 3, D) . Unlike neutrophils, eosinophil numbers were increased in the Tlr4 2/2 recipients, which is in agreement with a previous report that TLR4 signaling can suppress HDE-mediated eosinophilic inflammation. 35 Together, these data suggest that endotoxin is a major component in HDE that selectively sustains T H 17-mediated disease.
TLR4 expression in multiple cell types contributes to the sustained expansion of T H 17 cells
Tlr4 is expressed in a wide variety of cell types, including both radioresistant and radiosensitive cells. To gain a better understanding of which Tlr4-expressing cells are required for maintaining T H 17 responses, we adoptively transferred the fate-mapping T H 17 cells to reciprocal Tlr4 bone marrow chimeric J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 4 mice and challenged them with OVA alone or OVA/HDE. As expected, irradiated Tlr4 2/2 mice receiving bone marrow from Tlr4 2/2 animals had lower numbers and percentages of neutrophils and Tomato 1 cells compared with WT mice receiving WT marrow (Fig 4, A) . Interestingly, WT mice that received marrow from Tlr4 2/2 mice also had markedly fewer neutrophils and Tomato 1 T H 17 cells than WT control mice, indicating that TLR4 signaling in hematopoietic cells is critical for maintenance of lung T H 17 inflammation. Radioresistant Tlr4-expressing cells also contributed to neutrophilic inflammation because Tlr4 2/2 mice that received WT marrow also had reduced inflammation.
To determine more specifically in which lung cell types TLR4 is engaged by HDEs, we transferred T H 17 cells to conditional Tlr4 knockout animals, namely Sftpc-cre Tlr4 fl/fl or Cd11c-cre Tlr4 fl/fl mice, in which Tlr4 is deleted in lung epithelial cells or in CD11c
1 DCs and macrophages, respectively. Although Sftpc is not expressed in all mature epithelial cells in the lung, it is expressed in their precursors, and recombination events that occur in these cells are carried forward to mature epithelial cells. 36 After receiving T H 17 cells and challenge with OVA/HDE, Cd11c-Cre Tlr4 fl/fl and Sftpc-Cre Tlr4 fl/fl mice each had reduced neutrophil and Tomato 1 cell numbers compared with WT Tlr4 fl/fl mice (Fig 4, B) . Lungs from Cd11c-Cre Tlr4 fl/fl and Sftpc-Cre Tlr4 fl/fl mice also produced less IL-17A after restimulation ex vivo with OVA compared with lungs from WT Tlr4 fl/fl mice (Fig 4, C) . These results confirm that TLR4 signaling in Cd11c-expressing cells is critical for the maintenance of lung T H 17 inflammation and suggest that TLR4 activation in airway epithelial cells also contributes to the persistence of T H 17 responses in the lung.
cDCs are the only APCs capable of interacting with lung-resident T H 17 cells and reviving T H 17 expansion
Our finding that both antigen (OVA) and HDE are required for the amplification of OVA-specific T H 17 responses (Fig 2, B 1 cDCs and interstitial macrophages compared with those seen in mice exposed to OVA alone and that these increases were dependent on TLR4 (Fig 5, A) , whereas insignificant and weight loss (D) after the indicated number of days after adoptive transfer and first challenge. Data are combined from 2 independent experiments (n 5 5-8 animals per group). *P < .05 and **P < .01. to OVA with or without HDE. C-E, Shown also are inflammatory cells in BAL fluid (Fig 2, C) , percentages and numbers of Tomato 1 T H 17 cells (Fig 2, D) , and amounts of IL-17A in lung explant cultures (Fig 2, E) from Il17a/f 2/2 mice. Data are from 2 independent experiments (n 5 10 animals per group). F, Live cell imaging of precision-cut lung slices from WT recipients of T H 17 cells after multiple OVA/HDE exposures: Tomato
1
T H 17 cells (red) and E-cadherin-stained epithelia (blue). Zoomed-in images (top) are of the area denoted by the white rectangular inset (below). G and H, Weight loss (Fig 2, G) and lung function measurements (Fig 2, H) , including baseline pressure-volume curves (left) and the pressure-volume curve-derived K parameter (middle) and compliance (right) after adoptive transfer of T H 17 cells to WT mice and repeated challenge with OVA with or without HDE. *P < .05, **P < .01, ***P < .001, and ****P < .0001.
=
J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 4 changes were seen in lung CD103 1 cDCs and alveolar macrophage numbers. Analysis of costimulatory molecules indicated that OVA/ HDE only moderately increased CD86 MFI on cDCs but strongly increased CD40 MFI on both CD103
1 cDCs and CD11b 1 cDCs (Fig 5, B and C) . Consequently, the number of CD103 1 cDCs, CD11b 1 cDCs, and interstitial macrophages displaying CD40 was increased by HDE exposures. The observed changes in costimulatory molecules were also dependent on TLR4 because (Fig 4, A) or mice in which Tlr4 was deleted in either Cd11c-cre-expressing cells or Sftpc-cre-expressing lung epithelial cells (Fig 4, B) . Shown are BAL fluid inflammatory cell numbers and frequencies (Fig 4, A and B) , as well as IL-17A, in BAL fluid and lung explants (Fig 4, A and C) . Data are from 2 to 3 independent experiments. Fig 4, A, 6 to 12 animals per group; Fig 4, B, 2 to 7 animals per OVA alone-treated groups and 8 to 16 animals per OVA/HDE-treated groups. *P < .05, **P < .01, ***P < .001, and ****P < .0001. (Fig 5, B) and CD40 (Fig 5, C) displayed on the indicated APCs. Pooled data are from 2 independent experiment (n 5 6 animals per group). *P < .05, **P < .01, and ***P < .001. D, Uptake of OVA-Alexa Fluor 647 by different lung APC subsets after its administration together with HDE. E, Induction of TCR signaling by APCs sorted from lungs of OVA/HDE-treated mice. APCs were cocultured with naive CD4 T cells from OT-II mice crossed with Nur77-green fluorescent protein (GFP) reporter mice. GFP signals in the T cells were analyzed 20 hours later by means of confocal microscopy and flow cytometry.
they were greatly reduced in Tlr4 2/2 mice (Fig 5, B and C) . These data indicated that multiple lung APC subsets are activated by HDE.
Furthermore, we found that each of these APC subsets can take up fluorescently labeled OVA (OVA-Alexa Fluor 647) after its inhalation with HDE (Fig 5, D) , raising the question of which of these subsets is primarily responsible for T-cell activation. To address this, we sorted lung cDCs and interstitial macrophages from OVA/HDE-exposed mice and cocultured each cell type, with naive OVA-specific T cells bearing a fluorescent reporter of TCR activation (Nur77-green fluorescent protein). Whereas T cells cultured alone displayed negligible green fluorescent protein expression, both subsets of cDCs, as well as interstitial macrophages, induced TCR activation (Fig 5, E) . This suggested that multiple APCs might also be capable of interacting with and stimulating lung T H 17 cells.
To examine which APCs, CD103 1 cDCs, CD11b 1 cDCs, macrophages, or B cells might interact with T H 17 cells in the lungs, we performed live fluorescent imaging. This corroborated our flow cytometric data (Fig 5, B) , showing increases in CD11c 1 cell numbers in the lungs after T H 17 adoptive transfer and successive OVA/HDE challenges (Fig 6, A) . Higher-power microscopy revealed areas in which Tomato 1 T H 17 cells (red) and CD11c
1 cells (green) colocalized (yellow; Fig 6, B) , suggesting potential interaction of these cells in situ.
To confirm this, we stained lung slices with antibodies against CD103, Sirp1a, and CD88. The latter 2 markers were used to distinguish CD11b 1 cDCs, which are Sirp1a (Fig 6, D) . The latter were particularly potent in this regard, and IL-17A cytokine levels in culture supernatants were also highest for T H 17 cells cultured with CD11b 1 cDCs. To determine whether high amounts of T H 17-promoting cytokines in the 2 cDC subsets could explain their ability to drive T H 17 expansion and production of IL-17 ex vivo, we compared expression of Il23p19, Il1a, Il1b, and Il6 in various lung APCs in a microarray database (http://www.ncbi.nlm.nih.gov/geo/info/ linking.html; accession no. GSE64896).
30 CD11b 1 cDCs expressed the highest amounts of Il1b RNA (Fig 6, E) . However, interstitial macrophages produced more RNA encoding the other T H 17-promoting cytokines than did either CD11b 1 cDCs or CD103
1 cDCs. Analysis of T H 17 cells after culture with CD103 1 and CD11b 1 cDCs did not reveal clear differences in cytokine production (see Fig E5 in this article' s Online Repository at www.jacionline.org), suggesting that these different cDCs do not promote a unique phenotypic signature in the T H 17 cells.
IL-23 is reported to maintain T H 17 cells in some settings. 31, 37, 38 Therefore, even though both cDC subsets contained less Il23p19-specific mRNA than did interstitial macrophages, we nonetheless tested the requirement of IL-23 by comparing the T H 17 expansion in Il12p40-deficient mice (which lack both IL-23 and IL-12) and Il12p35-deficient mice (which lack IL-12 but retain IL-23). Il12p40-deficient mice had fewer Tomato 1 T H 17 cells (Fig 6, F) and IL-17A in BAL fluid and lung explants (Fig 6, G) than did WT mice or Il12p35-deficient mice. These data suggest that in this model IL-23 contributes to sustained clonal expansion of memory T H 17 cells and their production of IL-17A. , and WT mice all had similar levels of airway inflammation, Tomato 1 T H 17 cell numbers, and IL-17 cytokine levels (Fig 7, A-D) . (Fig 6, F) and IL-17A levels in BAL fluid (BALF) and supernatants of lung explants (Fig 6, G) from WT, Il12p35 2/2 , and Il12p40 2/2 mice that received adoptive transfer of in vitro-differentiated T H 17 cells and were challenged with OVA alone (white columns) or OVA/HDE (black columns). *P < .05, **P < .01, ***P < .001, and ****P < .0001.
J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 4 This result suggests 2 possibilities: that neither of these cDC subsets promoted T H 17 expansion and survival in vivo or that they have redundant activities in this regard. To distinguish between these alternatives, we adoptively transferred Tomato 
T H 17 cells to Flt3L
2/2 mice, which are deficient in both CD103
1 cDCs and CD11b 1 cDCs but have normal numbers of monocyte-derived DCs (interstitial macrophages) and alveolar macrophages. 41 After OVA/HDE challenge, Flt3l 2/2 mice had dramatically fewer neutrophils and Tomato 1 T H 17 cells and lower IL-17A levels compared with similarly challenged WT recipients (Fig 7, E and F) . Thus CD103 1 cDCs and CD11b 1 cDCs can each respond to HDE and independently sustain the selfrenewal of antigen-specific T H 17 cells, thereby maintaining lung T H 17-dependent inflammation and airway disease caused by inhaled antigens.
DISCUSSION
Elucidating the mechanisms by which T H 17 responses are sustained in the lungs is critical for an improved understanding of chronic pulmonary diseases. In addressing this question, we found that repeated inhalation of environmentally relevant HDE with antigen sustains T H 17 inflammation in the lungs and that, absent such environmental signals, these responses gradually diminish. Pathogenic T H 17 cells expressing the effector/memory T-cell marker CD44 were revived and sustained in the lungs specifically by TLR4 signaling and cDCs. These findings shed light on how lung-resident memory T H 17 cells can be reactivated and suggest that T H 17-dependent lung disease can be ameliorated by targeting these pathways.
HDE is a complex mixture of dead skin cells, allergens, microbial components, proteases, and protease inhibitors. (Fig 7, A, C , and E) and IL-17A levels in BAL fluid and lung explants (Fig 7, B , D, and F). Data are from 2 independent experiments for each genotype with 1 to 5 animals for mice challenged with OVA alone (open columns) and 8 to 23 mice challenged with OVA/HDE (black columns). *P < .05, **P < .01, ***P < .001, and ****P < .0001.
Surprisingly, the ability of HDE to maintain or expand T H 17 cells in the lungs was entirely dependent on TLR4 signaling. It is known that LPS is a potent adjuvant for inducing T H 17 responses to inhaled allergens, 14 and our current findings suggest that LPS is also required to maintain T H 17 inflammation of the lungs. Interestingly, chronic exposures of mice to OVA/HDE promoted even greater neutrophilia and more IL-17 production than did OVA/LPS, although amounts of endotoxin were similar, suggesting that additional components of HDE might be involved in TLR4 activation. Heat treatment of HDE did not modify its ability to expand and activate the adoptively transferred cells, suggesting that a heat-stable component of HDE or an endogenous TLR4 ligand released by tissue damage, such as the glycosaminoglycan hyaluronan, might be involved. Further studies will be necessary to confirm whether TLR4 ligands in the environment other than endotoxin can sustain lung T H 17 inflammation.
Expansion and activation of T H 17 cells by concomitant antigen and HDE exposures was accompanied by severe neutrophilic inflammation and apparent stiffening of the lungs, as well as cachexia. These pathologies share common features with chronic hypersensitivity pneumonitis, an interstitial lung disease caused by unresolved inflammation and tissue damage and commonly triggered by organic dust exposures, as well as other environmental agents. 42 Our work indicates that TLR4 might play a major role in forms of this disease that are characterized by severe T H 17 and neutrophilic inflammation. Moreover, our study might also be relevant to exacerbations of lung diseases, such as asthma. Higher numbers of neutrophils and levels of T H 17 cytokines were reported recently in the bronchial/nasal mucosa of patients with severe asthma compared with those with mild asthma and particularly in patients with severe asthma who have frequent exacerbations. 43, 44 The presence of endotoxin in house dust in urban environments has been associated with asthma symptoms, use of asthma medications, and wheezing. 45 It will be informative to learn whether endotoxin exposures also correlate with severe T H 17-associated asthma.
Our observation that sustained expansion of Tomato TLR4 is expressed by several cell types in the lungs, and recent studies have examined how cell-specific TLR4 signaling affects lung inflammation. Tlr4 expression in hematopoietic cells was shown to be necessary for IL-17A production and the consequent neutrophilic inflammation in an acute model of asthma, 16 but that study did not specifically examine T H 17 cells or the role of TLR4 in sustaining inflammation. Our current finding that expansion of adoptively transferred T H 17 cells is attenuated in animals lacking cDCs and also in mice selectively lacking Tlr4 in Cd11c-expressing cells suggests that cDCs are likely activated directly by TLR4 ligands to sustain lung T H 17 inflammation. This does not exclude a role for TLR4 signaling in other cell types, such as lung epithelial cells, and it will be important to gain a deeper understanding of how communication among different cell types coordinates responses to inhaled adjuvants and allergens. The requirement of TLR4 for T H 17 cell maintenance in the lungs suggests that targeting this pathway might be an effective therapeutic approach in patients with established T H 17-dependent lung diseases. 
METHODS
Bone marrow chimeric mice
Bone marrow cells (10 7 ) were transferred by means of retro-orbital injection to lethally irradiated recipient animals (9.25 Gray over 13 minutes), which were given water supplemented with 500 mg • mL 21 (Fig E3, A) and histograms showing MFI (Fig E3, B) (Fig E4, A) and in WT and Il17ra 2/2 mice (Fig E4, B) at the indicated number of days after adoptive transfer of T H 17 cells and the initial challenge. C, Shown are inflammation (top) and percentages and numbers of Tomato 1 cells (bottom)
in BALF, as well as IL-17A levels in lung explants in the indicated strains of mice (n 5 3-5 animals per group). *P < .05, **P < .01, ***P < .001, and ****P < .0001. 
